SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-17-007708
Filing Date
2017-05-02
Accepted
2017-05-02 09:51:31
Documents
5
Period of Report
2017-05-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K plxp20170501_8k.htm 8-K 25983
2 EXHIBIT 10.1 ex10-1.htm EX-10.1 176343
3 EXHIBIT 10.2 ex10-2.htm EX-10.2 40681
4 EXHIBIT 99.1 ex99-1.htm EX-99.1 18052
5 ex99-1img001.jpg GRAPHIC 2222
  Complete submission text file 0001437749-17-007708.txt   265682
Mailing Address 8285 EL RIO STREET SUITE 130 HOUSTON TX 77054
Business Address 8285 EL RIO STREET SUITE 130 HOUSTON TX 77054 (713) 842-1249
PLx Pharma Inc. (Filer) CIK: 0001497504 (see all company filings)

IRS No.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36351 | Film No.: 17803252
SIC: 2834 Pharmaceutical Preparations